1-20 of 80
Joe W. Gray
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 6618: Longitudinal, multimodal profiling of metastatic ER+ breast cancer on CDK4/6 inhibitor therapy

Allison L. Creason, Julian Egger, Cameron Watson, Shamilene Sivagnanam, Jia-Ren Lin, Koei Chin, Peter K. Sorger, Lisa M. Coussens, Zahi I. Mitri, Joe W. Gray, Gordon B. Mills, Jeremy Goecks
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 6618.
https://doi.org/10.1158/1538-7445.AM2023-6618
Published: 04 April 2023
View article titled, Abstract 6618: Longitudinal, multimodal profiling of metastatic ER+ breast cancer on CDK4/6 inhibitor therapy
Journal Articles

Abstract 4916: Spatial analysis of local drug induced changes in tumor microenvironment predicts effective treatment combinations in breast cancer

Zuzana Tatarova, Dylan C. Blumberg, Gordon B. Mills, Lisa M. Coussens, Oliver Jonas, Joe W. Gray
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4916.
https://doi.org/10.1158/1538-7445.AM2023-4916
Published: 04 April 2023
View article titled, Abstract 4916: Spatial analysis of local drug induced changes in tumor microenvironment predicts effective treatment combinations in breast cancer
Journal Articles

Abstract 5431: 3D multiplexed tissue imaging reconstruction and optimized region-of-interest (ROI) selection through deep learning model of channels embedding

Erik Burlingame, Luke Ternes, Eun Na Kim, Joe W. Gray, Young Hwan Chang
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 5431.
https://doi.org/10.1158/1538-7445.AM2023-5431
Published: 04 April 2023
View article titled, Abstract 5431: 3D multiplexed tissue imaging reconstruction and optimized region-of-interest (ROI) selection through deep learning model of channels embedding
Journal Articles

Abstract 5630: Robust spatial biomarker discovery through multi-platform multiplex image analysis of breast cancer clinical cohorts

Jennifer R. Eng, Elmar Bucher, Zhi Hu, Melinda Sanders, Bapsi Chakravarthy, Jennifer Pietenpol, Rosalie C. Sears, Summer Gibbs, Joe W. Gray, Koei Chin
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 5630.
https://doi.org/10.1158/1538-7445.AM2023-5630
Published: 04 April 2023
View article titled, Abstract 5630: Robust spatial biomarker discovery through multi-platform multiplex image analysis of breast cancer clinical cohorts
Journal Articles

Abstract 6149: Prognostic tumor microenvironment subtypes in triple-negative breast cancer

Jennifer R. Eng, Elmar Bucher, Zhi Hu, Melinda Sanders, Bapsi Chakravarthy, Summer Gibbs, Koei Chin, Jennifer Pietenpol, Joe W. Gray
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 6149.
https://doi.org/10.1158/1538-7445.AM2022-6149
Published: 15 June 2022
View article titled, Abstract 6149: Prognostic tumor microenvironment subtypes in triple-negative breast cancer
Journal Articles

Abstract 2149: Biomarker-driven selection of polyADP ribose polymerase inhibitors (PARPi)-based combination therapies in patients with metastatic triple negative breast cancer (mTNBC)

Zahi I. Mitri, Evthokia A. Hobbs, Shaun M. Goodyear, Jeong Youn Lim, Joanna Pucilowska, Brett Johnson, Allison L. Creason, Courtney Betts, Lisa M. Coussens, Shannon McWeeney, Christopher L. Corless, Joe W. Gray, Gordon B. Mills
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 2149.
https://doi.org/10.1158/1538-7445.AM2022-2149
Published: 15 June 2022
View article titled, Abstract 2149: Biomarker-driven selection of polyADP ribose polymerase inhibitors (PARPi)-based combination therapies in patients with metastatic triple negative breast cancer (mTNBC)
Journal Articles

Abstract P5-13-05: Multiplex spatial systems analysis of responses to spatially separate nanoliter doses of drug predicts systemic immune-modulating combination treatments in breast cancer

Zuzana Tatarova, Dylan C Blumberg, Lisa M Coussens, Gordon B Mills, Oliver Jonas, Joe W Gray
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P5-13-05.
https://doi.org/10.1158/1538-7445.SABCS21-P5-13-05
Published: 15 February 2022
View article titled, Abstract P5-13-05: Multiplex spatial systems analysis of responses to spatially separate nanoliter doses of drug predicts systemic immune-modulating combination treatments in breast cancer
Journal Articles

Abstract LB010: SMMART Program: A multi-omics tumor board with a focus on breast cancer

Ben L. Kong, Brett E. Johnson, Jamie M. Keck, Souraya Mitri, Patrick Leyshock, Jayne M. Stommel, Kiara Siex, Marlana Klinger, Christina L. Zheng, Rochelle Williams-Belizaire, Shannon McWeeney, Jeremy Goecks, Annette Kolodzie, Alexander R. Guimaraes, George V. Thomas, Christopher L. Corless, Zahi I. Mitri, Joe W. Gray, Gordon B. Mills, Raymond C. Bergan
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): LB010.
https://doi.org/10.1158/1538-7445.AM2021-LB010
Published: 01 July 2021
View article titled, Abstract LB010: SMMART Program: A multi-omics tumor board with a focus on breast cancer
Journal Articles

Abstract 4929: Leveraging multi-omics tumor boards for precision medicine in the OHSU SMMART Treatments Program

Jamie M. Keck, Swapnil Parmar, Ben Kong, Zahi Mitri, Christopher Corless, Annette Kolodzie, Allison Creason, Jeremy Goecks, Patrick Leyshock, Kiara Siex, Brett E. Johnson, Janice Patterson, Laura Heiser, Anastasiya Olson, Matt Viehdorfer, Georgia Mayfield, Jennifer Laverdure, Joe W. Gray, Gordon B. Mills, Raymond C. Bergan
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4929.
https://doi.org/10.1158/1538-7445.AM2019-4929
Published: 01 July 2019
View article titled, Abstract 4929: Leveraging multi-omics tumor boards for precision medicine in the OHSU SMMART Treatments Program
Journal Articles

CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion

Xuanmao Jiao, Marco A. Velasco-Velázquez, Min Wang, Zhiping Li, Hallgeir Rui, Amy R. Peck, James E. Korkola, Xuelian Chen, Shaohua Xu, James B. DuHadaway, Sandra Guerrero-Rodriguez, Sankar Addya, Daniela Sicoli, Zhaomei Mu, Gang Zhang, Andres Stucky, Xi Zhang, Massimo Cristofanilli, Alessandro Fatatis, Joe W. Gray, Jiang F. Zhong, George C. Prendergast, Richard G. Pestell
Journal: Cancer Research
Cancer Res (2018) 78 (7): 1657–1671.
https://doi.org/10.1158/0008-5472.CAN-17-0915
Published: 01 April 2018
View article titled, CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion
Open the PDF for CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion in another window
Includes: Supplementary data
Journal Articles

Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells

Rina Gendelman, Heming Xing, Olga K. Mirzoeva, Preeti Sarde, Christina Curtis, Heidi S. Feiler, Paul McDonagh, Joe W. Gray, Iya Khalil, W. Michael Korn
Journal: Cancer Research
Series: Author Choice
Cancer Res (2017) 77 (7): 1575–1585.
https://doi.org/10.1158/0008-5472.CAN-16-0512
Published: 02 April 2017
View article titled, Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells
Open the PDF for Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Abstract 1347: NTRK1/TRKA as a therapeutic target in castration resistant prostate cancer

James E. Korkola, Moqing Liu, Rebecca Smith, Tiera Liby, Joe W. Gray
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 1347.
https://doi.org/10.1158/1538-7445.AM2016-1347
Published: 15 July 2016
View article titled, Abstract 1347: NTRK1/TRKA as a therapeutic target in castration resistant prostate cancer
Journal Articles

Abstract 603: Consensus molecular subtyping through a community of experts advances unsupervised gene expression-based disease classification and facilitates clinical translation

Justin Guinney, Rodrigo Dienstmann, Xin Wang, Aurelien de Reynies, Andreas Schlicker, Charlotte Soneson, Laetitia Marisa, Paul Roepman, Gift Nyamundanda, Paolo Angelino, Brian Bot, Jeffrey S. Morris, Iris Simon, Sarah Gerster, Evelyn Fessler, Felipe de Sousa e Melo, Edoardo Missiaglia, Hena Ramay, David Barras, Krisztian Homicsko, Dipen Maru, Ganiraju Manyam, Bradley Broom, Valerie Boige, Ted Laderas, Ramon Salazar, Joe W. Gray, Josep Tabernero, Rene Bernards, Stephen Friend, Pierre Laurent-Puig, Jan P. Medema, Anguraj Sadanandam, Lodewyk Wessels, Mauro Delorenzi, Scott Kopetz, Louis Vermeulen, Sabine Tejpar
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 603.
https://doi.org/10.1158/1538-7445.AM2015-603
Published: 01 August 2015
View article titled, Abstract 603: Consensus molecular subtyping through a community of experts advances unsupervised gene expression-based disease classification and facilitates clinical translation
Journal Articles

Abstract 721: Mevalonate pathway mediates acquired anti-HER2 treatment resistance in HER2+ breast cancer

Huizhong Hu, Lukas Simon, Lanfang Qin, Agostina Nardone, Chad Shaw, Gary Chamness, Laura Heiser, Nicholas Wang, Joe W. Gray, C. Kent Osborne, Rachel Schiff
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 721.
https://doi.org/10.1158/1538-7445.AM2015-721
Published: 01 August 2015
View article titled, Abstract 721: Mevalonate pathway mediates acquired anti-HER2 treatment resistance in HER2+ breast cancer
Journal Articles

Abstract P5-05-03: Clonal evolution of the HER2 L755S mutation leads to acquired HER-targeted therapy resistance that can be reversed by the irreversible HER1/2 inhibitor afatinib

Xiaowei Xu, Agostina Nardone, Huizhong Hu, Lanfang Qin, Sarmistha Nanda, Laura M Heiser, Nicholas Wang, Kyle R Covington, Edward S Chen, Alexander Renwick, Tao Wang, Carmine De Angelis, Alejandro Contreras, Carolina Gutierrez, Suzanne AW Fuqua, Gary C Chamness, Chad Shaw, David A Wheeler, Joe W Gray, Susan G Hilsenbeck, Mothaffar F Rimawi, C Kent Osborne, Rachel Schiff
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P5-05-03.
https://doi.org/10.1158/1538-7445.SABCS14-P5-05-03
Published: 01 May 2015
View article titled, Abstract P5-05-03: Clonal evolution of the HER2 L755S mutation leads to acquired HER-targeted therapy resistance that can be reversed by the irreversible HER1/2 inhibitor afatinib
Journal Articles

Abstract PD6-2: FoxA1 gene amplification in ER+ breast cancer mediates endocrine resistance by increasing IL-8

Xiaoyong Fu, Rinath Jeselsohn, Emporia F Hollingsworth, Dolores Lopez-Terrada, Chad J Creighton, Agostina Nardone, Martin Shea, Laura M Heiser, Pavana Anur, Nicholas Wang, Catie Grasso, Paul Spellman, Carolina Gutierrez, Mothaffar F Rimawi, Susan G Hilsenbeck, Joe W Gray, Myles Brown, C K Osborne, Rachel Schiff
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): PD6-2.
https://doi.org/10.1158/1538-7445.SABCS14-PD6-2
Published: 01 May 2015
View article titled, Abstract PD6-2: FoxA1 gene amplification in ER+ breast cancer mediates endocrine resistance by increasing IL-8
Journal Articles

Abstract S6-07: Detrimental effects of sequential compared to concurrent treatment of pertuzumab plus T-DM1 in HER2+ breast cancer cell lines

James E Korkola, Moqing Liu, Tiera Liby, Laura Heiser, Heidi Feiler, Joe W Gray
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): S6-07.
https://doi.org/10.1158/1538-7445.SABCS14-S6-07
Published: 01 May 2015
View article titled, Abstract S6-07: Detrimental effects of sequential compared to concurrent treatment of pertuzumab plus T-DM1 in HER2+ breast cancer cell lines
Journal Articles

Abstract P3-05-13: Overexpression of insulin receptor substrate 4 can mediate acquired resistance to lapatinib-containing regimens in HER2+ breast cancer cells

Lanfang Qin, Maria B Hahn, Xiaoyong Fu, Martin J Shea, Mario Giuliano, Sarmistha Nanda, Xiaowei Xu, Huizhong Hu, Sung Yun Jung, Laura M Heiser, Nicholas Wang, Joe W Gray, Susan G Hilsenbeck, Chad Creighton, Chad A Shaw, Gary C Chamness, Dean P Edwards, Sabrina Herrera, Carolina Gutierrez, C Kent Osborne, Rachel Schiff
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P3-05-13.
https://doi.org/10.1158/1538-7445.SABCS14-P3-05-13
Published: 01 May 2015
View article titled, Abstract P3-05-13: Overexpression of insulin receptor substrate 4 can mediate acquired resistance to lapatinib-containing regimens in HER2+ breast cancer cells
Journal Articles

Abstract A58: Wnt signaling pathway components are associated with telomerase activity in breast cancer

Imke Listerman, Francesca S. Gazzaniga, Laura M. Heiser, Jason J. Lukas, Ted Goldstein, David Haussler, Joe W. Gray, Elizabeth H. Blackburn
Journal: Cancer Research
Cancer Res (2011) 71 (18_Supplement): A58.
https://doi.org/10.1158/1538-7445.FBCR11-A58
Published: 28 October 2014
View article titled, Abstract A58: Wnt signaling pathway components are associated with telomerase activity in breast cancer
Journal Articles

Abstract 5502: Metrics other than potency reveal systematic variation in responses to cancer drugs

Mohammad Fallahi-Sichani, Saman Honarnejad, Laura M. Heiser, Joe W. Gray, Peter K. Sorger
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 5502.
https://doi.org/10.1158/1538-7445.AM2014-5502
Published: 01 October 2014
View article titled, Abstract 5502: Metrics other than potency reveal systematic variation in responses to cancer drugs